Clinical Study of U1RNP70KD,Sm-D,SSB and Β2gp1 Autoantigens, Their Cdna Cloning, Expressing in E.coli, Epitopes Mapping and Serodiagnostic Value

沈南,吕良敬,陈顺乐,薛峰,陆瑜,杨程德,郑捷,赵阴环,叶萍

DOI: https://doi.org/10.3969/j.issn.0253-9934.2000.05.003

2000-01-01

Abstract:Objective Studies on the expression of recombinant autoantigens U1RNP70KD, Sm D, SSB and β2GP1 and evaluation of their serodiagnostic value. Methods By adapting reverse transcription PCR technology, we obtained the cDNA clones encoding β2GP1, β2GP1 D5, U1RNP70KD, U1BD, Sm D and SSB autoantigens. The recombinant proteins were expressed by the bacterial expression plasmid pGEX 2T and then idnetified and purified. The locations of epitopes of β2GP1 and U1RNP70KD were analysed by competitive inhibition ELISA and IBT respectively. CIE or IBT defined positive autoimmune sera were tested by ELISA or IBT of the recombinant autoantigens. Results The β2GP1 D5 and U1BD were confirmed to be the major epitopes of β2GP1 and U1RNP70KD respectively. There was a high correlation between binding values of IgG anti β2GP1 and IgG aCL antibodies ( r =0.667),and there was also relevance between binding values of IgM anti β2GP1, and IgM aCL antibodies ( r =0.553). The analysis by IBT demonstrated that 96%(48/50) of anti U1RNP70KD positive sera and 67.4%(29/43) of anti SSB positive sera could recognize the recombinant proteins. And 9 sera samples which showed 13.5kD positive band in IBT method also had positive reaction with recombinant Sm D by ELISA method. Conclusion The recombinant autoantigens have good specificity and can be used in epitopes mapping further and in clinical use for serodiagnosis.(Shanghai Med J, 2000,23∶263 266)